OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Glucagon-Like Peptide-1 Receptor Agonist Cases Reported to United States Poison Centers, 2017–2022
Christopher E. Gaw, Hannah L. Hays, Cydney A. Kemp, et al.
Journal of Medical Toxicology (2024) Vol. 20, Iss. 2, pp. 193-204
Open Access | Times Cited: 8
Christopher E. Gaw, Hannah L. Hays, Cydney A. Kemp, et al.
Journal of Medical Toxicology (2024) Vol. 20, Iss. 2, pp. 193-204
Open Access | Times Cited: 8
Showing 8 citing articles:
Association between Semaglutide and Non-Arteritic Anterior Ischemic Optic Neuropathy: A Multinational Population-Based Real-World Study
Chien-Chih Chou, Ssu-Yu Pan, Yi‐Jing Sheen, et al.
Ophthalmology (2024)
Closed Access | Times Cited: 17
Chien-Chih Chou, Ssu-Yu Pan, Yi‐Jing Sheen, et al.
Ophthalmology (2024)
Closed Access | Times Cited: 17
EVALUATING BOWEL OBSTRUCTION and ILEUS EVENTS in PATIENTS on GLP-1 RECEPTOR AGONISTS: A SYSTEMATIC REVIEW and META-ANALYSIS
Lama Alfehaid, Majed Alyami, Sumaya N. Almohareb, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
Lama Alfehaid, Majed Alyami, Sumaya N. Almohareb, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
The Impact of Glucagon-Like Peptide-1 Receptor Agonists on Pharmacokinetics and Toxicokinetics: Is a New Diagnostic and Therapeutic Framework Needed?
James D. Whitledge, Joseph M. Kennedy, C. James Watson, et al.
Journal of Medical Toxicology (2025)
Closed Access
James D. Whitledge, Joseph M. Kennedy, C. James Watson, et al.
Journal of Medical Toxicology (2025)
Closed Access
Clinical Outcomes of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) and Glucagon-Like Peptide-1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist (GLP-1/GIP RA) Exposures Presenting to the Emergency Department
H. Gärtner, Roy D. Simmons, Herbert Z. Wan, et al.
Annals of Pharmacotherapy (2025)
Closed Access
H. Gärtner, Roy D. Simmons, Herbert Z. Wan, et al.
Annals of Pharmacotherapy (2025)
Closed Access
Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events
Long He, Qiuyu Li, Yongfeng Yang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Long He, Qiuyu Li, Yongfeng Yang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Ocular adverse events associated with GLP-1 receptor agonists: a Real-World Study Based on the FAERS database and network pharmacology
Zhiwei Luo, Xiang Li, Cui-Ting Chen, et al.
Expert Opinion on Drug Safety (2024)
Closed Access | Times Cited: 2
Zhiwei Luo, Xiang Li, Cui-Ting Chen, et al.
Expert Opinion on Drug Safety (2024)
Closed Access | Times Cited: 2
Increased reporting of accidental overdose with glucagon-like peptide-1 receptor agonists: a population-based study
Roger S. McIntyre, Angela T.H. Kwan
Expert Opinion on Drug Safety (2024), pp. 1-6
Closed Access | Times Cited: 1
Roger S. McIntyre, Angela T.H. Kwan
Expert Opinion on Drug Safety (2024), pp. 1-6
Closed Access | Times Cited: 1
Therapeutic errors involving diabetes medications reported to United States poison centers
Ashley Thurgood Giarman, Hannah L. Hays, Jaahnavi Badeti, et al.
Injury Epidemiology (2024) Vol. 11, Iss. 1
Open Access
Ashley Thurgood Giarman, Hannah L. Hays, Jaahnavi Badeti, et al.
Injury Epidemiology (2024) Vol. 11, Iss. 1
Open Access
